<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font25">development </span>
   <span class="font23">phase </span>
   <span class="font22">research </span>
   <span class="font21">cost </span>
   <span class="font20">epidemic </span>
   <span class="font20">infectious </span>
   <span class="font18">candidates </span>
   <span class="font18">costs </span>
   <span class="font17">million </span>
   <span class="font15">disease </span>
   <span class="font15">million) </span>
   <span class="font14">probability </span>
   <span class="font14">success </span>
   <span class="font14">(–) </span>
   <span class="font14">associated </span>
   <span class="font13">preclinical </span>
   <span class="font13">data </span>
   <span class="font13">end </span>
   <span class="font12">R&amp;amp;D </span>
   <span class="font12">ready </span>
   <span class="font12">diseases </span>
   <span class="font12">study </span>
   <span class="font12">estimates </span>
   <span class="font12">new </span>
   <span class="font12">analysis </span>
   <span class="font12">{border-style </span>
   <span class="font12">available </span>
   <span class="font12">candidate </span>
   <span class="font12">literature </span>
   <span class="font12">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">clinical </span>
   <span class="font11">billion </span>
   <span class="font11">number </span>
   <span class="font11">portfolio </span>
   <span class="font11">vaccines </span>
   <span class="font11">Number </span>
   <span class="font11">minimum </span>
   <span class="font11">pipeline </span>
   <span class="font11">preparedness </span>
   <span class="font11">scenario </span>
   <span class="font11">low </span>
   <span class="font11">analyses </span>
   <span class="font11">diseases. </span>
   <span class="font11">licensure </span>
   <span class="font11">reported </span>
   <span class="font11">funding </span>
   <span class="font11">high </span>
   <span class="font11">optimisation </span>
   <span class="font11">pipelines </span>
   <span class="font11">developers </span>
   <span class="font11">evidence </span>
   <span class="font11">pharmaceutical </span>
   <span class="font11">previous </span>
   <span class="font11">priority </span>
   <span class="font11">(appendix). </span>
   <span class="font11">CI) </span>
   <span class="font11">Health </span>
   <span class="font11">based </span>
   <span class="font11">investment </span>
   <span class="font11">investments </span>
   <span class="font11">need </span>
   <span class="font11">needed </span>
   <span class="font11">CEPI </span>
   <span class="font11">However, </span>
   <span class="font11">PoS </span>
   <span class="font11">development, </span>
   <span class="font11">different </span>
   <span class="font11">diseases, </span>
   <span class="font11">drug </span>
   <span class="font11">given </span>
   <span class="font11">global </span>
   <span class="font11">identified </span>
   <span class="font11">likely </span>
   <span class="font11">organisations </span>
   <span class="font11">outcomes </span>
   <span class="font11">stochastic </span>
   <span class="font11">survey </span>
   <span class="font10">Decision </span>
   <span class="font10">N/A </span>
   <span class="font10">Phase </span>
   <span class="font10">access </span>
   <span class="font10">analysis, </span>
   <span class="font10">developing </span>
   <span class="font10">distributions </span>
   <span class="font10">experience </span>
   <span class="font10">information </span>
   <span class="font10">potential </span>
   <span class="font10">px; </span>
   <span class="font10">self-reported </span>
   <span class="font10">severe </span>
   <span class="font10">{font-family </span>
   <span class="font10">(by </span>
   <span class="font10">EID </span>
   <span class="font10">advancing </span>
   <span class="font10">collab: </span>
   <span class="font10">costs, </span>
   <span class="font10">development. </span>
   <span class="font10">disease, </span>
   <span class="font10">factors </span>
   <span class="font10">fever </span>
   <span class="font10">font-size </span>
   <span class="font10">higher </span>
   <span class="font10">lower </span>
   <span class="font10">needs </span>
   <span class="font10">progressing </span>
   <span class="font10">published </span>
   <span class="font10">response </span>
   <span class="font10">single </span>
   <span class="font10">study. </span>
   <span class="font10">technologies </span>
   <span class="font10">trial </span>
   <span class="font10">Ebola </span>
   <span class="font10">Masi </span>
   <span class="font10">achieve </span>
   <span class="font10">achieving </span>
   <span class="font10">design, </span>
   <span class="font10">double; </span>
   <span class="font10">drivers </span>
   <span class="font10">fever, </span>
   <span class="font10">health </span>
   <span class="font10">methods </span>
   <span class="font10">parameters </span>
   <span class="font10">product </span>
   <span class="font10">project </span>
   <span class="font10">range). </span>
   <span class="font10">respiratory </span>
   <span class="font10">risk </span>
   <span class="font10">successfully </span>
   <span class="font10">suggests </span>
   <span class="font10">technical </span>
   <span class="font10">(table </span>
   <span class="font10">Data </span>
   <span class="font10">Econ </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Expected </span>
   <span class="font10">First, </span>
   <span class="font10">High </span>
   <span class="font10">Low </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Research </span>
   <span class="font10">Rift </span>
   <span class="font10">Second, </span>
   <span class="font10">Table </span>
   <span class="font10">Third, </span>
   <span class="font10">US$ </span>
   <span class="font10">Valley </span>
   <span class="font10">assuming </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">business </span>
   <span class="font10">collected </span>
   <span class="font10">confirmed </span>
   <span class="font10">costs. </span>
   <span class="font10">demonstrate </span>
   <span class="font10">drive </span>
   <span class="font10">estimate </span>
   <span class="font10">exist </span>
   <span class="font10">findings </span>
   <span class="font10">findings. </span>
   <span class="font10">funders </span>
   <span class="font10">future </span>
   <span class="font10">haemorrhagic </span>
   <span class="font10">indirect </span>
   <span class="font10">industry </span>
   <span class="font10">interpretation </span>
   <span class="font10">limited </span>
   <span class="font10">models </span>
   <span class="font10">outbreaks </span>
   <span class="font10">pathogens </span>
   <span class="font10">progress </span>
   <span class="font10">provide </span>
   <span class="font10">provided </span>
   <span class="font10">range) </span>
   <span class="font10">regression </span>
   <span class="font10">required </span>
   <span class="font10">resource </span>
   <span class="font10">solid; </span>
   <span class="font10">success, </span>
   <span class="font10">success. </span>
   <span class="font10">suggest </span>
   <span class="font10">syndrome, </span>
   <span class="font10">testing </span>
   <span class="font10">thrombocytopenia </span>
   <span class="font10">used </span>
   <span class="font10">variables </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(phase </span>
   <span class="font10">COVID- </span>
   <span class="font10">Congo </span>
   <span class="font10">Epidemic </span>
   <span class="font10">PoS/low </span>
   <span class="font10">PoS–high </span>
   <span class="font10">Preclinical </span>
   <span class="font10">Preparedness </span>
   <span class="font10">Total </span>
   <span class="font10">World </span>
   <span class="font10">accounting </span>
   <span class="font10">active </span>
   <span class="font10">acute </span>
   <span class="font10">advance </span>
   <span class="font10">analytical </span>
   <span class="font10">assumption </span>
   <span class="font10">average </span>
   <span class="font10">bold </span>
   <span class="font10">centre </span>
   <span class="font10">collection </span>
   <span class="font10">complexity </span>
   <span class="font10">confidence </span>
   <span class="font10">contributed </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">database </span>
   <span class="font10">differ </span>
   <span class="font10">draw </span>
   <span class="font10">drew </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">emergency </span>
   <span class="font10">estimates, </span>
   <span class="font10">expected </span>
   <span class="font10">explanatory </span>
   <span class="font10">focusing </span>
   <span class="font10">identify </span>
   <span class="font10">increase </span>
   <span class="font10">model </span>
   <span class="font10">model. </span>
   <span class="font10">modelling </span>
   <span class="font10">numbers </span>
   <span class="font10">outcome </span>
   <span class="font10">overall </span>
   <span class="font10">overcome </span>
   <span class="font10">owing </span>
   <span class="font10">percentile </span>
   <span class="font10">phase, </span>
   <span class="font10">platform </span>
   <span class="font10">portfolios </span>
   <span class="font10">probabilities </span>
   <span class="font10">projects </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">scope </span>
   <span class="font10">set </span>
   <span class="font10">smaller </span>
   <span class="font10">stage </span>
   <span class="font10">statistical </span>
   <span class="font10">status </span>
   <span class="font10">substantially </span>
   <span class="font10">supported </span>
   <span class="font10">total </span>
   <span class="font10">track </span>
   <span class="font10">upper </span>
   <span class="font10">use </span>
   <span class="font10">using </span>
   <span class="font10">variations </span>
   <span class="font10">various </span>
   <span class="font10">versus </span>
   <span class="font10">    </span>
  </p>
 </body>
</html>
